相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term effects of BRAF inhibitors in melanoma treatment: friend or foe?
Sarah Sloot et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Vemurafenib for Leptomeningeal Melanomatosis
Niklas Schaefer et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Multiple Congenital Melanocytic Nevi and Neurocutaneous Melanosis Are Caused by Postzygotic Mutations in Codon 61 of NRAS
Veronica A. Kinsler et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study
Paolo A. Ascierto et al.
LANCET ONCOLOGY (2013)
GNA11 and N-RAS mutations: alternatives for MAPK pathway activating GNAQ mutations in primary melanocytic tumours of the central nervous system
M. Gessi et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2013)
Primary Melanoma of the CNS in Children Is Driven by Congenital Expression of Oncogenic NRAS in Melanocytes
Malin Pedersen et al.
CANCER DISCOVERY (2013)
Neuropathology of neurocutaneous melanosis: histological foci of melanotic neurones and glia may be undetectable on MRI
Veronica A. Kinsler et al.
ACTA NEUROPATHOLOGICA (2012)
Primary Leptomeningeal Melanocytosis in a 10-Year-Old Girl: A Challenging Diagnosis With a Poor Prognosis
Kirsten L. Brunsvig et al.
JOURNAL OF CHILD NEUROLOGY (2011)
Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system
Heidi V. N. Kusters-Vandevelde et al.
ACTA NEUROPATHOLOGICA (2010)
Neurocutaneous melanosis in association with Dandy-Walker malformation: case report and literature review
S. Schreml et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2008)
分享论文
